Come up with a name for your new list and we'll add to it:
PRIMACYT raised a round of funding on March 05, 2010. Investors include
Bundesministerium fur Bildung und Forschung.
PRIMACYT has developed serum-free long-term culture techniques for hepatocytes. These technologies allow utilization of human and other mammalian hepatocytes as biosensors for screening purposes, whil…